We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

Back to rankings

28 hedge funds and large institutions have $16.1M invested in Fibrocell Science Inc. in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

7% more capital invested

Capital invested by funds: $15.1M → $16.1M (+$1.03M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 30 → 28 (-2)

Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
10
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$155K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$71.5K
3
Renaissance Technologies
Renaissance Technologies
New York
+$49.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$30.1K
5
PPA
Parametric Portfolio Associates
Washington
+$29.4K

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$40K
2
Goldman Sachs
Goldman Sachs
New York
-$28.2K
3
State Street
State Street
Massachusetts
-$8K
4
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$7K
5
Morgan Stanley
Morgan Stanley
New York
-$277
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$11.1M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.74M -$11 -1 -0%
MP
3
MSD Partners
New York
$1.39M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$788K +$7.06K +636 +0.8%
Renaissance Technologies
5
Renaissance Technologies
New York
$174K +$49.3K +4,440 +34%
BlackRock
6
BlackRock
New York
$140K +$155K +13,969 New
Cambridge Investment Research Advisors
7
Cambridge Investment Research Advisors
Iowa
$136K +$1.69K +152 +1%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$120K +$510 +46 +0.4%
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$73K – – –
SCA
10
STALEY CAPITAL ADVISERS
Pennsylvania
$66K – – –
Bank of New York Mellon
11
Bank of New York Mellon
New York
$64K -$11 -1 -0%
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$64K +$71.5K +6,448 New
Goldman Sachs
13
Goldman Sachs
New York
$48K -$28.2K -2,542 -35%
FSA
14
Franklin Street Advisors
North Carolina
$33K – – –
CCA
15
Conservest Capital Advisors
Pennsylvania
$33K +$37K +3,333 New
HVC
16
Healthcare Value Capital
New Jersey
$32K – – –
Northern Trust
17
Northern Trust
Illinois
$32K +$6.63K +598 +23%
PPA
18
Parametric Portfolio Associates
Washington
$27K +$29.4K +2,652 New
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$27K +$30.1K +2,709 New
Creative Planning
20
Creative Planning
Kansas
$25K +$20K +1,800 +270%
ARTA
21
A.R.T. Advisors
New York
$21K +$3.72K +335 +19%
Morgan Stanley
22
Morgan Stanley
New York
$17K -$277 -25 -1%
TRCT
23
Tower Research Capital (TRC)
New York
$4K +$1.09K +98 +34%
Wells Fargo
24
Wells Fargo
California
$3K +$1.48K +133 +66%
Manulife (Manufacturers Life Insurance)
25
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
1
2

FCSC Hedge Fund Activity: Q1 2017 in Review

28 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q1 2017, worth a combined $16.1M — up 6.8% from $15.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new FCSC positions and 4 closed out — a net gain of 2 holders — while 10 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $155K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $40K sold.

  • 28 institutional investors held Fibrocell Science Inc. (FCSC) as of Q1 2017, down from 30 in Q4 2016.
  • Funds reported $16.1M of Fibrocell Science Inc. stock for Q1 2017, up 6.8% quarter-over-quarter.
  • 6 funds opened new Fibrocell Science Inc. positions in Q1 2017 and 4 closed out, a net change of +2 holders.
  • The largest Fibrocell Science Inc. buyer in Q1 2017 was BlackRock, an estimated $155K added.
  • The largest Fibrocell Science Inc. seller in Q1 2017 was Virtu KCG Holdings, an estimated $40K sold.

Based on aggregated 13F filings for Q1 2017.